Archive for May 6th, 2011

CTIC Reverse split. Pipeline updates ANDS ISIS DEPO NABI INHX

May 06, 2011 No Comments by

Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS) reported after hours yesterday that they expect to receive data through 8 and 12 weeks for all patients in their Phase 2b trial of ANA598 for HCV during 3Q this year. Antiviral response data through 24 weeks are expected in 4Q 2011. Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) updated yesterday saying […]

Daily News Read more